A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2004
11/18/2004	WO2004099194A1 4-(2-furoyl)aminopiperidine compound useful as therapeutic agent for itching
11/18/2004	WO2004098632A1 Skin collagen production promoter
11/18/2004	WO2004098606A1 Composition comprising a pde4 inhibitor and shuil-1r ii
11/18/2004	WO2004098605A1 Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
11/18/2004	WO2004098578A2 Composition comprising a pde4 inhibitor and a tnf-alfa antagonist selected from infliximab, adalimumab, cdp870 and cdp517
11/18/2004	WO2004098543A2 Use of oligogalacturonide-type oligosaccharides in cosmetic, food or dermatological compositions in order to stimulate epidermal cell differentiation
11/18/2004	WO2004073593A3 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications
11/18/2004	WO2004062686A3 Therapeutic use of modulators of notch
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040230043 Novel neurotrophic factors
11/18/2004	US20040230037 Chemokine receptor materials and methods
11/18/2004	US20040229923 Mixing a racemic mixture of enantiomers of pyrrolo[2,3-d]pyrimidine compounds in a solvent, with a resolving compound having a defined stereospecificity, to form a solution and with resolving agent being capable of binding with enantiomers to form a precipitate collecting precipitate and purifying
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229884 Sodium channel blockers
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229876 Quinoline derivatives and quinazoline derivatives having azolyl group
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229851 2-Propylidene-19-nor-vitamin D compounds
11/18/2004	US20040229835 Immunostimulatory nucleic acid molecules
11/18/2004	US20040229833 Therapeutic use of cis-element decays in vivo
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229333 Electroprocessed fibrin-based matrices and tissues
11/18/2004	US20040229260 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases
11/18/2004	US20040228908 vitamin C, vitamin B complex, carotene, vitamin E, a fragrance, a thickener and a surfactant; acne treamtent
11/18/2004	US20040228889 Use of N-arylmethylene ethylenediaminetriacetates, N-arylmethylene iminodiacetated or N,N'-diarylmethylene ethylenediamineacetates as doners of NO
11/18/2004	US20040228857 administration of a human or humanized antibody expressed and glycosylated in a chinese hamster ovaries (CHO) cell expression system to treat T-cell mediated disorders, autoimmune disorders, cancer and infections; vasculitis, arthritis, lupus, psoriasis, multiple sclerosis, graft versus host disease
11/18/2004	US20040228855 Method for treating symptoms of diabetes
11/18/2004	DE202004013288U1 Dermatological composition containing active agents from Brassica, useful for treating e.g. shingles, psoriasis and skin rashes, also for skin care
11/18/2004	CA2748670A1 Dermal micro organs, methods and apparatuses for producing and using the same
11/18/2004	CA2524469A1 Method, apparatus, and composition for treating acne
11/17/2004	EP1477490A1 Pyrrolopyrimidine derivative
11/17/2004	EP1477489A1 Pyrrolopyrimidine derivatives
11/17/2004	EP1477483A1 Vitamin d3 derivatives and remedies using the same
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004	EP1477170A1 Antipruritics
11/17/2004	EP1477166A1 The use of riluzol combined with excipients and additives for the treatment of disorders characterised by hyperproliferation of keratinocytes, in particular neurodermitis and psoriasis
11/17/2004	EP1477165A2 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
11/17/2004	EP1476752A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476541A2 Novel cytokine zcytor17 ligand
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476461A2 Immune-modulating peptide made of s. aureus enterotoxin b
11/17/2004	EP1476460A2 A nucleic acid encoding a g-protein-coupled receptor; and uses thereof
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476456A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/17/2004	EP1476454A1 Binding epitopes for helicobacter pylori and use thereof
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1476206A1 Compositions comprising undifferentiated fetal cells for the treatment of skin disordes
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476159A2 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1476131A2 Compositions and methods for delivery of skin cosmeceuticals
11/17/2004	EP1476130A1 Preparations containing diol
11/17/2004	EP1476128A2 Lipase inhibiting composition
11/17/2004	EP1476127A1 Nsaid-containing topical formulations that demonstrate chemopreventive activity
11/17/2004	EP1476019A1 Aqueous antiseptic based on bispyridiniumalkanes
11/17/2004	EP1476018A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1303283B1 Use of noble metals for the manufacture of a medicament to treat hyperproliferative skin disorders and diseases
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1283672B1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1171120A4 Methods for alleviating discomfort of a hot flash and compositions therefor
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	EP0679160B1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
11/17/2004	CN1547584A Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methods
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547478A Use of fucans in the treatment of adhesions, arthritis and psoriasis
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1547475A Dermal therapy using phosphate derivatives of electron transfer agents
11/17/2004	CN1547464A Prolonged release bioadhesive therapeutic systems
11/17/2004	CN1547460A Composite powders and skin preparations for external use containing the same
11/17/2004	CN1546167A Prescription for preventing and treating fin rot of turbot
11/17/2004	CN1546164A Spraying agent of transfer factor
11/17/2004	CN1546148A Ointment for expelling the wind and cold, removing toxic substances, removing blood stasis and its preparation
11/17/2004	CN1546139A Specific medicine for eradicating condyloma acuminatum
11/17/2004	CN1546128A Oil for treating burns, scalds and sores
11/17/2004	CN1546122A Compound medical ointment for treating tinea on manus and pedes
11/17/2004	CN1546121A Medicine for treating psoriasis and its preparation
11/17/2004	CN1546100A Externally used non-toxic bacteriostatic bactericidal traditional medicine preparation and its preparing technics
11/17/2004	CN1546077A Blood streak removing medicine
11/17/2004	CN1546076A Speckle removing medicine
11/17/2004	CN1546060A Arsenic compound recipe for treating tuberculosis and dermatopathy
11/17/2004	CN1546056A Application of shitosan in ultraviolet resistant field
11/17/2004	CN1546053A Vitamin B12 composition preparation and its application
11/17/2004	CN1546045A Compound medicinal tincture for treating tinea on manus and pedes
11/17/2004	CN1546030A Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
11/17/2004	CN1546001A Multifunctional skin makeup cream and preparation method thereof
11/17/2004	CN1176072C Vitamin D3 analogs

1 ... 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 ... 1065